Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Dejan Radeski"'
Autor:
Won-Seog Kim, Jake Shortt, Pier Luigi Zinzani, Natalya Mikhaylova, Ana Marin-Niebla, Dejan Radeski, Vincent Ribrag, Eva Domingo Domènech, Ahmed Sawas, Karenza Alexis, Michael Emig, Linta Garcia, Andre Overesch, Kerstin Pietzko, Steven Horwitz
Publikováno v:
HemaSphere, Vol 7, p e6843062 (2023)
Externí odkaz:
https://doaj.org/article/70ae321f2d424a66bbf78d0f537758bb
Autor:
Rebecca J. Leeman-Neill, Craig R. Soderquist, Francesca Montanari, Patricia Raciti, David Park, Dejan Radeski, Mahesh M. Mansukhani, Vundavalli V. Murty, Susan Hsiao, Bachir Alobeid, Govind Bhagat
Publikováno v:
Haematologica, Vol 107, Iss 1 (2020)
Plasmablastic lymphoma (PBL) is a rare and clinically aggressive neoplasm that typically occurs in immunocompromised individuals, including those infected with human immunodeficiency virus (HIV) and solid organ allograft recipients. Most prior studie
Externí odkaz:
https://doaj.org/article/252f392f937d47819103a14e653b32a6
Autor:
Eliza A Hawkes, Jake Shortt, Greg Hapgood, Belinda A. Campbell, Dejan Radeski, Sze Ting Lee, Maya Latimer, Stephen Lade, Joshua W.D. Tobin, Henry Miles Prince, Bryone J. Kuss, D Purtill
Publikováno v:
Internal Medicine Journal. 52:1806-1817
Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous disease group accounting for 10% of non-Hodgkin lymphomas. PTCL patients have typically poorer outcomes compared to aggressive B-cell lymphomas. However, such outcomes are heavily dependen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb98485529ec656eda264f771a13b798
https://doi.org/10.1111/imj.15595
https://doi.org/10.1111/imj.15595
Autor:
Owen A. O'Connor, Simon Jones, Yuan Zhang, Serge Cremers, Hongfeng Jiang, Jennifer Heinen, Dejan Radeski, Xavier Jirau-Serrano, Luigi Scotto, Govind Bhagat, Daniela Hoehn, Kelly Zullo, Maximilian Lombardo, Paul Johannet, Jennifer E. Amengual
Purpose: Pan-class histone deacetylase (HDAC) inhibitors are effective treatments for select lymphomas. Isoform-selective HDAC inhibitors are emerging as potentially more targeted agents. HDAC6 is a class IIb deacetylase that facilitates misfolded pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e65c138e0e4b7e1256e44af768ef5d82
https://doi.org/10.1158/1078-0432.c.6524379.v1
https://doi.org/10.1158/1078-0432.c.6524379.v1
Autor:
Owen A. O'Connor, Simon Jones, Yuan Zhang, Serge Cremers, Hongfeng Jiang, Jennifer Heinen, Dejan Radeski, Xavier Jirau-Serrano, Luigi Scotto, Govind Bhagat, Daniela Hoehn, Kelly Zullo, Maximilian Lombardo, Paul Johannet, Jennifer E. Amengual
Peripheral blood mononuclear cells (PBMCs) were separated from whole blood by Ficoll-Paque layering. (A) Concentration : effect relationship was determined for ACY-1215 at 24 and 48 hours in PBMCs. No cytotoxicity was observed after 24 and 48 hours o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b1ddbfe259b925651164d93eff2ddec
https://doi.org/10.1158/1078-0432.22460022
https://doi.org/10.1158/1078-0432.22460022
Autor:
Won Seog Kim, Jake Shortt, Pier Luigi Zinzani, Natalya Mikhaylova, Ana Marin-Niebla, Dejan Radeski, Vincent Ribrag, Eva Domingo Domenech, Ahmed Sawas, Karenza Alexis, Michael Emig, Linta Garcia, Andre Overesch, Kerstin Pietzko, Steven Horwitz
Publikováno v:
Cancer Research. 83:CT024-CT024
PTCLs are aggressive hematologic malignancies often with poor prognoses; for patients with R/R PTCL there is no standard-of-care therapy and novel treatments are required. AFM13 is a tetravalent, bispecific Innate Cell Engager (ICE ® ) that binds CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e5b18de21a3793af1f3559926215c9d
https://doi.org/10.1158/1538-7445.am2023-ct024
https://doi.org/10.1158/1538-7445.am2023-ct024
Autor:
Susan Hsiao, Patricia Raciti, Vundavalli V. Murty, Rebecca J. Leeman-Neill, David C. Park, Bachir Alobeid, Francesca Montanari, Dejan Radeski, Craig R. Soderquist, Govind Bhagat, Mahesh Mansukhani
Publikováno v:
Haematologica
Plasmablastic lymphoma (PBL) is a rare and clinically aggressive neoplasm that typically occurs in immunocompromised individuals, including those infected with human immunodeficiency virus (HIV) and solid organ allograft recipients. Most prior studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d6a526c1dcd2c50df7548c240fa1035
https://doi.org/10.3324/haematol.2020.267294
https://doi.org/10.3324/haematol.2020.267294
Autor:
Daniel Magee, Talia Shepherd, Zoe Krisnadi, Ho‐Cing Victor Yau, Shaun Samuelson, Dejan Radeski
Publikováno v:
ANZ journal of surgeryReferences. 92(7-8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2330d9896b7d62c5c10a11f13a6c2825
https://pubmed.ncbi.nlm.nih.gov/34874098
https://pubmed.ncbi.nlm.nih.gov/34874098
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e564-e567
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e47dd3714a4ff8e52bf80db7b3f47436
https://doi.org/10.1016/j.clml.2019.05.014
https://doi.org/10.1016/j.clml.2019.05.014
Autor:
Jillian Wells, Kate Newland, Stephen Lade, Mark P. Hertzberg, Amit Khot, H. Miles Prince, Carrie van der Weyden, Sally Mapp, David Joske, Odette Buelens, Christopher McCormack, Dejan Radeski, Christine Khoo, Eliza A Hawkes, Jake Shortt, Friyana K. Bhabha, Belinda A. Campbell
Publikováno v:
Australasian Journal of Dermatology. 62
Primary cutaneous lymphomas represent a heterogeneous group of T- and B-cell lymphomas with distinct clinical presentations, histopathologic features, treatment approaches and outcomes. The cutaneous T-cell lymphomas, which include mycosis fungoides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33a2664ad740f56a1928171586222668
https://doi.org/10.1111/ajd.13467
https://doi.org/10.1111/ajd.13467